BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32390238)

  • 21. Clinical prognostic factors in locally advanced nasopharyngeal carcinoma in Moroccan population.
    Raissouni S; Rais G; Lkhoyaali S; Aitelhaj M; Mouzount H; Mokrim M; Razine R; El Kacemi H; Mrabti H; Benjaafar N; Errihani H
    Gulf J Oncolog; 2013 Jul; 1(14):35-44. PubMed ID: 23996865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
    Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E
    Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
    Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
    Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Taarnhøj GA; Christensen IJ; Lajer H; Fuglsang K; Jeppesen MM; Kahr HS; Høgdall C
    Cancer; 2018 Mar; 124(5):943-951. PubMed ID: 29211304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
    Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
    J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum standardized lymph node uptake value could be an important predictor of recurrence and survival in patients with cervical cancer.
    Nakamura K; Joja I; Nagasaka T; Haruma T; Hiramatsu Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():77-82. PubMed ID: 24275232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
    Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
    Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of lymph node ratio in node-positive cervical cancer patients.
    Joo JH; Kim YS; Nam JH
    Medicine (Baltimore); 2018 Jul; 97(30):e11711. PubMed ID: 30045335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
    Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
    Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer.
    Hwang KT; Kim YA; Kim J; Chu AJ; Chang JH; Oh SW; Hwang KR; Chai YJ
    Breast Cancer Res Treat; 2017 May; 163(1):71-82. PubMed ID: 28194538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.